Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
J&J pays $2.2B upfront for Ollin to challenge Roche’s Vabysmo
J&J has struck a deal to buy Ollin Biosciences for $2.2 billion upfront, establishing itself as a threat to Roche’s blockbuster eye drug Vabysmo.
Nick Paul Taylor
Nov 16, 2026 9:40am
Lilly gets fresh myelofibrosis option via $1.5B Calytrix buyout
Nov 16, 2026 9:49am
Chinese scientists fired after child dies in gene editing study
Nov 16, 2026 4:30am
CG’s newest late-stage bladder cancer results broaden potential
Nov 16, 2026 2:05pm
Helus scores ph. 3 depression win for modified psychedelic
Nov 16, 2026 10:40am
Biogen inks $411M pact for TrimTech’s protein degrader skills
Nov 16, 2026 10:00am
More News
Aclaris drops TSLP program after failing ph. 2 eczema test
Nov 16, 2026 8:20am
Flagship commits £100M for London biotech incubation outpost
Nov 16, 2026 6:09am
DNA med-focused biotech Seawolf surfaces with $1.2B Sanofi pact
Nov 16, 2026 5:00am
Sofinnova books $815M fund toward up-and-coming ‘global leaders’
Nov 16, 2026 2:00am
See more stories